Craig Sizer, Co-Founder and Chairman

Mr. Sizer has 20 years of experience in corporate finance and private equity transactions. He posses extensive entrepreneurial and capital fund raising experience with a firsthand knowledge of a variety of established and growth business sectors.

He started his career as a Series 7 stock broker for a boutique firm in New York over 20 years ago. Mr. Sizer’s additional business experience includes terms as Managing Director of a Private Equity firm. Also, during that period Mr. Sizer co-founded B.E. OVERSEAS INVESTMENT GROUP, which was later sold to a 30 year old small cap NASDAQ company. Prior to that he worked with high growth companies preparing to go public, as well as initially providing them capital.

His leadership has helped many organizations, small to medium size, move through the development/start up phase with relative ease.

Keith Houlihan, Co-Founder and President

Mr. Houlihan was the founder and Managing Director of Meridian Solutions Group, Inc., an international health care search and placement firm based in Vero Beach, Florida, with a branch in Santiago, Chile. Mr. Houlihan has extensive experience in human capital recruitment and has worked closely with Fortune 500 health care executives as they grow and reshape their organizations for success. He entered the South American market via his professional ties with Chile, and developed a pilot program for health care professionals seeking entry to the US market.

Prior to his tenure at Meridian, Mr. Houlihan held the position of Vice President of Business Development at Capital Resource and Investment Group, a Miami-based private equity firm. He later founded MedicarePro Limitada, which was created to position itself as a leader in quality home medical devices and products. His personal experience in the health care sector brings immediate benefit to Sanomedics with his noteworthy list of accomplishments and professional relationships within the Health Care and Pharmacy sectors. Mr. Houlihan attended Southern Illinois University.

Gary O’Hara, Chief Technology Officer

Mr. O’Hara brings over 25 years of experience in medical device product innovation and business development to the Sanomedics team. He was the co-founder of Intelligent Medical Systems (IMS) and built the company to more than 200 employees while making “Inc. 500’s” list of fastest growing U.S. private companies. He invented the first commercialized infrared tympanic thermometer (FirstTemp® and Genius® brands) for which he was cited as Inventor of the Year by the San Diego Patent Law Association. In 1993, the Company was acquired by Fortune 500 pharmaceutical manufacturer American Home Products.

Prior to his work in the medical device industry, he co-founded Tryom, Inc. which was a developer and manufacturer of handheld personal information devices and electronic games of strategy such as backgammon, chess and contract bridge.

Mr. O’Hara has also been active in the seed and startup phases of many ventures through his involvement with the Tech Coast Angels which is an organization of 150 investors that invest in and mentor early stage technology and biomedical companies.

>Mr. O’Hara holds numerous patents related to medical devices and electronic computer games and holds B.S. and M.S. degrees in Electrical Engineering from the University of Michigan as well as an MBA from Eastern Michigan University.

Steve Relis, Chief Financial Officer

Mr. Relis has extensive experience working with many clients in various industries including high tech, real estate, construction, manufacturing and professional services. Prior to joining the firm he was the Chief Accounting Officer of Gilat Latin America, a wholly owned subsidiary of Gilat Satellite Networks Ltd (NASDAQ – GILTF). He also served as the Chief Accounting Officer and Interim Chief Financial Officer of Ursus Telecom Corporation (NASDAQ – UTCC). He was an audit manager with Deloitte and Touche in New York and Ernst & Young in Miami. At Ernst & Young he was part of the entrepreneurial services group, which specializes in supporting the needs of aggressive growth companies.

Mr. Relis received a B.S. in Business from Long Island University in 1985 and is a licensed Certified Public Accountant in the States of Florida and New York. He is a member of the American, Florida and New York Institutes of Certified Public Accounting.

Dom L. Gatto, Operations

His professional experience includes many different areas in the medical industry. He has been involved in areas ranging from product management to executive management. He acquired his knowledge of the medical device industry over the last twenty years from a hands on perspective. He started out as a product manager for one of the world’s largest producers of medical textile products – CoNco Medical Corporation. Upon departing this large multi-national medical concern, he assumed the position “jack of all trades” in guiding a small, developing medical device company (Merocel Corporation) into becoming a world leader in its field of synthetic biocompatible polymers for use in microsurgical. After enjoying considerable success as the head of marketing and product development, his efforts turned to business development. He conducted a feasibility study to determine the viability of a new business division for minimally invasive medical instruments. When he found that such a venture was worthwhile and could be developed, FessCo, Inc. was formed to design, develop, manufacture, and market minimally invasive endoscopic devices. FessCo, a Delaware Corporation wholly owned by Warburg-Pincus, was financially successful within in its first 6 months of sales, exceeding over $2 million in revenues. He had successfully developed and launched a line of innovative minimally invasive handheld cutting instruments and a self-irrigating powered tissue removal system, the first of its kind, for the ENT market. Within its third year of operation, FessCo, along with Merocel Corporation, were folded into Xomed Surgical Products and the operations eventually acquired by Medtronic. His proven track record allowed him to obtain the necessary support to form a start-up entity, Medtrek Corporation, to design, develop, and market minimally invasive ENT devices.

In 2000, after establishing the innovative product line and worldwide distribution rights for the products with Olympus, he divested his interest in Medtrek and joined the breast cancer start-up company Acueity, Inc. as Executive Vice President of Operations. He skillfully guided Acueity’s product development, sales, marketing and production. Under his leadership, Acueity was featured in Time magazine as one of the top five medical technologies for breast cancer detection and treatment. Since departing Acueity in 2005, he has been an executive advisor to startup entities; Acclarent, Inc. (recently acquired by Johnson & Johnson) and Vibrynt, Inc. In addition, he served on the board of directors of Solos Endoscopy. He is a co-founder of Colibri Healthcare and Acceptent Corporation, both early stage diagnostic companies.

Over his career he has developed, launched and successfully managed over 75 medical devices ranging from polymer based disposables to integrated imaging systems. He holds 5 patents and is co-inventor on three patent pending medical devices. Mr. Gatto graduated Magna Cum Laude with a BS degree in Marketing from Quinnipiac University and attended the Executive Management program at the John E. Anderson School of Business – UCLA. He is currently an advisor and mentor at Notre Dame University’s Mendoza School of Business for entrepreneurial studies.